Clinical Trials Now Underway
A global phase 3 trial for leniolisib for people with APDS is currently underway.
The primary objective of the clinical trial is to evaluate the long-term safety and tolerability of leniolisib
in patients with APDS.
Download a Phase 3 Trial Summary information sheet
to share with your doctor.
Sign-up for APDS updates.
Leniolisib is an investigational product and there is no guarantee that leniolisib will be approved for use by the FDA in the United States, nor become commercially available.
For additional information, you may contact Pharming Medical Information at email@example.com
Sign up for APDS updates